Antifracture Efficacy of Currently Available Therapies for Postmenopausal Osteoporosis

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.1, 2011-01, pp. : 65-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis – usefulness of alendronate and risedronate

By Iwamoto Jun Takeda Tsuyoshi Sato Yoshihiro

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2743-2756

Informa Healthcare

Access to resources Recommend Favorite

Prospect of Combination and Sequential Therapies for Postmenopausal Osteoporosis

Current Pharmaceutical Design, Vol. 23, Iss. 41, 2018-02 ,pp. : 6251-6255

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy and safety of long-term bisphosphonates in postmenopausal osteoporosis

By Miller Paul D

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2253-2258

Informa Healthcare

Access to resources Recommend Favorite

Which therapies warranted for postmenopausal osteoporosis?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 370, 2002-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Osteoporosis therapies

By Mulligan L. Grandjean N.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 6, 2000-06 ,pp. : 755-766

Informa Healthcare

Access to resources Recommend Favorite